Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1994 Mar;69(3):529–536. doi: 10.1038/bjc.1994.96

Prognostic significance of histopathological subtypes in stage I pure yolk sac tumour of the ovary.

H Sasaki 1, M Furusato 1, S Teshima 1, T Kiyokawa 1, A Tada 1, S Aizawa 1, T Yamabe 1, S Tsugane 1, Y Terashima 1
PMCID: PMC1968864  PMID: 7510118

Abstract

The correlation between histological subtype [endodermal sinus (ES), polyvesicular vitelline (PV), glandular (G) and hepatoid (H) subtypes] and the prognosis of pure yolk sac tumours (YSTs) of the ovary was investigated. From 1964 to 1989, 35 patients with YSTs were treated with primary surgery and adjuvant chemotherapy. The prevalence of histological subtypes was as follows: 14 patients had a single subtype, either ES (12) or G (2); 12 patients had two subtypes, ES+G (4), ES+PV (3), ES+H (4) or G+H (1); six patients had three subtypes, ES+P+H (4) or ES+G+H (2); and three patients had all four subtypes. Multivariate analysis showed that important predictors were FIGO stage, chemotherapeutic regimen and residual tumour size. However, for stage I, multivariate analysis showed that the histological subtype was a superior predictor to the subclassification of FIGO stage I, age or chemotherapeutic regimen (P = 0.03). Kaplan-Meier analysis showed that YSTs composed of an admixture of three or four subtypes was associated with a better prognosis than those composed of one or two subtypes (P < 0.01), other variables being constant.

Full text

PDF
529

Images in this article

531Figure 1
on p.531
531Figure 2
on p.531
531Figure 3
on p.531
532Figure 4
on p.532

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bradof J. E., Hakes T. B., Ochoa M., Golbey R. Germ cell malignancies of the ovary: treatment with vinblastine, actinomycin D, bleomycin and cisplatin containing chemotherapy combinations. Cancer. 1982 Sep 15;50(6):1070–1075. doi: 10.1002/1097-0142(19820915)50:6<1070::aid-cncr2820500609>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  2. Carlson R. W., Sikic B. I., Turbow M. M., Ballon S. C. Combination cisplatin, vinblastine, and bleomycin chemotherapy (PVB) for malignant germ-cell tumors of the ovary. J Clin Oncol. 1983 Oct;1(10):645–651. doi: 10.1200/JCO.1983.1.10.645. [DOI] [PubMed] [Google Scholar]
  3. Davis T. E., Loprinzi C. L., Buchler D. A. Combination chemotherapy with cisplatin, vinblastine, and bleomycin for endodermal sinus tumor of the ovary. Gynecol Oncol. 1984 Sep;19(1):46–52. doi: 10.1016/0090-8258(84)90156-2. [DOI] [PubMed] [Google Scholar]
  4. Einhorn L. H., Donohue J. Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med. 1977 Sep;87(3):293–298. doi: 10.7326/0003-4819-87-3-293. [DOI] [PubMed] [Google Scholar]
  5. Gershenson D. M., Copeland L. J., Kavanagh J. J., Cangir A., Del Junco G., Saul P. B., Stringer C. A., Freedman R. S., Edwards C. L., Wharton J. T. Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vincristine, dactinomycin, and cyclophosphamide. Cancer. 1985 Dec 15;56(12):2756–2761. doi: 10.1002/1097-0142(19851215)56:12<2756::aid-cncr2820561206>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  6. Gershenson D. M., Morris M., Cangir A., Kavanagh J. J., Stringer C. A., Edwards C. L., Silva E. G., Wharton J. T. Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin. J Clin Oncol. 1990 Apr;8(4):715–720. doi: 10.1200/JCO.1990.8.4.715. [DOI] [PubMed] [Google Scholar]
  7. HUNTINGTON R. W., Jr, MORGENSTERN N. L., SARGENT J. A., GIEM R. N., RICHARDS A., HANFORD K. C. Germinal tumors exhibiting the endodermal sinus pattern of Teilum in young children. Cancer. 1963 Jan;16:34–47. doi: 10.1002/1097-0142(196301)16:1<34::aid-cncr2820160106>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  8. Huntington R. W., Jr, Bullock W. K. Yolk sac tumors of the ovary. Cancer. 1970 Jun;25(6):1357–1367. doi: 10.1002/1097-0142(197006)25:6<1357::aid-cncr2820250614>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  9. Jimerson G. K., Woodruff J. D. Ovarian extraembryonal teratoma. I. Endodermal sinus tumor. Am J Obstet Gynecol. 1977 Jan 1;127(1):73–79. doi: 10.1016/0002-9378(77)90317-9. [DOI] [PubMed] [Google Scholar]
  10. Julian C. G., Barrett J. M., Richardson R. L., Greco F. A. Bleomycin, vinblastine, and cis-platinum in the treatment of advanced endodermal sinus tumor. Obstet Gynecol. 1980 Sep;56(3):396–401. [PubMed] [Google Scholar]
  11. Kawai M., Kano T., Furuhashi Y., Mizuno K., Nakashima N., Hattori S. E., Kazeto S., Iida S., Ohta M., Arii Y. Prognostic factors in yolk sac tumors of the ovary. A clinicopathologic analysis of 29 cases. Cancer. 1991 Jan 1;67(1):184–192. doi: 10.1002/1097-0142(19910101)67:1<184::aid-cncr2820670131>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  12. Kurman R. J., Norris H. J. Endodermal sinus tumor of the ovary: a clinical and pathologic analysis of 71 cases. Cancer. 1976 Dec;38(6):2404–2419. doi: 10.1002/1097-0142(197612)38:6<2404::aid-cncr2820380629>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  13. NEUBECKER R. D., BREEN J. L. Embryonal carcinoma of the ovary. Cancer. 1962 May-Jun;15:546–556. doi: 10.1002/1097-0142(196205/06)15:3<546::aid-cncr2820150314>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  14. Nogales F. F., Jr, Matilla A., Nogales-Ortiz, galera-Davidson H. L. Yolk sac tumors with pure and mixed polyvesicular vitelline patterns. Hum Pathol. 1978 Sep;9(5):553–566. doi: 10.1016/s0046-8177(78)80136-1. [DOI] [PubMed] [Google Scholar]
  15. Pinkerton C. R., Pritchard J., Spitz L. High complete response rate in children with advanced germ cell tumors using cisplatin-containing combination chemotherapy. J Clin Oncol. 1986 Feb;4(2):194–199. doi: 10.1200/JCO.1986.4.2.194. [DOI] [PubMed] [Google Scholar]
  16. Prat J., Bhan A. K., Dickersin G. R., Robboy S. J., Scully R. E. Hepatoid yolk sac tumor of the ovary (endodermal sinus tumor with hepatoid differentiation): a light microscopic, ultrastructural and immunohistochemical study of seven cases. Cancer. 1982 Dec 1;50(11):2355–2368. doi: 10.1002/1097-0142(19821201)50:11<2355::aid-cncr2820501122>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  17. Smales E., Peckham M. J. Chemotherapy of germ-cell ovarian tumours: first-line treatment with etoposide, bleomycin and cisplatin or carboplatin. Eur J Cancer Clin Oncol. 1987 May;23(5):469–474. doi: 10.1016/0277-5379(87)90305-1. [DOI] [PubMed] [Google Scholar]
  18. TEILUM G. Endodermal sinus tumors of the ovary and testis. Comparative morphogenesis of the so-called mesoephroma ovarii (Schiller) and extraembryonic (yolk sac-allantoic) structures of the rat's placenta. Cancer. 1959 Nov-Dec;12:1092–1105. doi: 10.1002/1097-0142(195911/12)12:6<1092::aid-cncr2820120606>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  19. Talerman A., Haije W. G., Baggerman L. Serum alphafetoprotein (AFP) in diagnosis and management of endodermal sinus (yolk sac) tumor and mixed germ cell tumor of the ovary. Cancer. 1978 Jan;41(1):272–278. doi: 10.1002/1097-0142(197801)41:1<272::aid-cncr2820410138>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  20. Taylor M. H., Depetrillo A. D., Turner A. R. Vinblastine, bleomycin, and cisplatin in malignant germ cell tumors of the ovary. Cancer. 1985 Sep 15;56(6):1341–1349. doi: 10.1002/1097-0142(19850915)56:6<1341::aid-cncr2820560621>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  21. Teilum G. Classification of endodermal sinus tumour (mesoblatoma vitellinum) and so-called "embryonal carcinoma" of the ovary. Acta Pathol Microbiol Scand. 1965;64(4):407–429. doi: 10.1111/apm.1965.64.4.407. [DOI] [PubMed] [Google Scholar]
  22. Ulbright T. M., Roth L. M., Brodhecker C. A. Yolk sac differentiation in germ cell tumors. A morphologic study of 50 cases with emphasis on hepatic, enteric, and parietal yolk sac features. Am J Surg Pathol. 1986 Mar;10(3):151–164. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES